Calls for papers

15 June 2024

Cell-based Therapeutics

We announce a call for papers for our upcoming special issue focusing on Cell-Based Therapeutics. This issue aims to showcase the transformative impacts of cell-based therapies on clinical practice and the pharmaceutical industry, featuring innovative treatments like genetically reprogrammed T cells for lymphoid cancers and adipose-derived stem cells for Crohn’s disease.

Editors

  • Yan Ma, Research Associate, Spatial Navigation and Memory Unit, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Maryland, USA.
  • Dr. Meijie Tian, NIH-funded researcher, Oncogenomic section, Genetics Branch, Center of Cancer Research, National Cancer Institute (NCI).
  • Dr. Mohd Hussain Shah, Ophthalmology Department, Ohio State University; current research fellow at National Eye Institute (NEI).

Featured Topics

  • Targeted Delivery and Biodistribution: How cell-based therapies utilize cellular properties for precise therapeutic delivery.
  • Advanced Sense-and-Response Functions: The dynamic capabilities of these therapies to monitor and respond to disease states.
  • Sustained Endogenous Drug Delivery: Exploring the persistence and long-term benefits of therapeutic cells in vivo.
  • Challenges and Solutions: Addressing the hurdles in adoption and commercialization, including cell source stability, safety, and scalable manufacturing processes.
  • Next-Generation Engineering Approaches: We are particularly interested in manuscripts discussing innovative engineering approaches such as genome and epigenome editing, synthetic biology, and biomaterial-mediated immune modulation that enhance therapeutic efficacy and address current limitations.

Purpose of This Special Issue

Our goal is to bridge the gap between basic and clinical research, enhancing the translation of groundbreaking research into clinical applications. We are looking for submissions that discuss novel methods in cell collection, isolation, modification, and production, as well as clinical applications focusing on safety, efficacy, and regulatory compliance.

Preferred Types of Submissions

  • Original studies on the characterization and utilization of therapeutic cells.
  • Reviews on molecular strategies enhancing cell-based therapeutic functions.
  • Brief communications on novel technologies and approaches in cell production.

Why should you publish in a Special Issue?

  • Articles in a Special Issue are collectively published significantly enhancing their visibility and discoverability by other researchers.
  • Special Issue content is downloaded twice as frequently compared to articles in regular issues.
  • Special Issue articles receive 20% more citations in the same period than those published in standard issues.
  • Each submission to this Special Issue will undergo rigorous peer review by a minimum of two independent experts, ensuring the quality, originality, and novelty of the published work.

Submission Guidelines

Submissions should demonstrate originality, relevance to genetic research and biotechnological applications, rigorous methodology, and compliance with ethical standards.

Submission Period: 15 June to 15 December 2024

Instructions for submitting the article

1. Write a Cover letter: State that you are submitting your article for the special issue on Cell-Based Therapeutics.
2. Select the correct Section: When submitting your article, choose the "Cell-Based Therapies" section.
3. Submit your article: Follow the steps on this link to submit your article: Submit your article

Join us in advancing the field of cell-based therapies by contributing your groundbreaking research to this special issue. Your work will be handled by well-known experts in the field, ensuring thorough review and wide recognition.

15 August 2024 - Announcement

Microbiome and Cancer

We are pleased to announce an upcoming call for papers for our special issue on The Microbiome and Cancer (Immunotherapy): Unraveling the Interactions and Therapeutic Potential. This issue will focus on advancing our understanding of the intricate relationship between the microbiome and cancer, particularly in the context of immunotherapy, with the goal of translating these insights into innovative therapeutic approaches.

Objective of This Special Issue

As the field of oncology evolves, the role of the microbiome in influencing cancer development and treatment responses is increasingly recognized as a pivotal area of research. This special issue aims to bring together high-quality contributions that explore the molecular mechanisms by which the microbiome modulates immune responses, affects tumor microenvironments, and impacts the efficacy of cancer immunotherapies. Our objective is to provide a comprehensive resource that advances both basic science and clinical applications in this rapidly growing field.

Scope of Submissions

We invite rigorous and impactful submissions that reflect the breadth and depth of research in this area:

  • Original research that provides new insights into the interactions between the microbiome and cancer, with a focus on immunotherapy outcomes.
  • In-depth reviews that critically assess current knowledge and propose future directions for integrating microbiome research into cancer treatment paradigms.
  • Brief communications highlighting novel methodologies or preliminary findings that have the potential to influence future research and therapeutic strategies.

Why Contribute to This Special Issue?

  • Scientific Significance: Contributing to this special issue provides an opportunity to present your research in a field that is at the forefront of cancer treatment innovation.
  • Broad Impact: Your work will be part of a specialized issue aimed at influencing both academic research and clinical practices.
  • Interdisciplinary Collaboration: This issue seeks to foster collaboration between microbiologists, oncologists, immunologists, and other experts, creating a platform for interdisciplinary dialogue and discovery.

We encourage submissions from leading researchers and practitioners who are contributing to the understanding of the microbiome's role in cancer and immunotherapy. Detailed submission guidelines and deadlines will be announced shortly. We look forward to your contributions that will help shape the future of cancer therapy.

30 August 2024 - Announcement

Cell Death: Mechanisms, decisions, and therapeutic approaches

We are excited to announce an upcoming call for papers for a special issue focusing on Cell Death: Mechanisms, Decisions, and Therapeutic Approaches. This issue will delve into the complex processes that govern cell death, exploring how these mechanisms influence disease progression and therapeutic outcomes. By highlighting cutting-edge research in this field, we aim to foster new insights and innovations that could lead to transformative therapies across a range of diseases.

Purpose of This Special Issue

Our goal is to deepen the understanding of cell death mechanisms, bridging fundamental research with clinical applications to develop new therapeutic approaches. We are seeking submissions that investigate the molecular pathways of apoptosis, necrosis, autophagy, and other cell death processes, and how these can be modulated for therapeutic benefit. Additionally, we welcome studies that explore the implications of cell death in disease progression and therapy, offering insights into how these processes can be harnessed or inhibited in clinical settings.

Preferred Types of Submissions

  • Original studies on the molecular mechanisms driving different forms of cell death and their implications in diseases.
  • Reviews on the latest therapeutic strategies targeting cell death pathways, including small molecules, biologics, and gene therapies.
  • Brief communications on novel techniques for modulating cell death in preclinical and clinical settings, as well as innovative therapeutic approaches aimed at controlling cell fate.

Why Should You Publish in a Special Issue?

Publishing in a Special Issue offers a unique opportunity to maximize the impact of your research while benefiting from a streamlined process. Here’s why submitting to a Special Issue is an excellent choice for your work:

  1. Enhanced Visibility and Discoverability:

    • Articles in Special Issues are part of a themed collection that naturally draws the attention of researchers and practitioners interested in the specific topic. This targeted focus ensures that your work is more visible and discoverable by the right audience.
    • Special Issues are frequently highlighted by journals, further increasing the prominence of your article. This collective publication approach significantly boosts your research’s exposure.

  2. Increased Downloads and Citations:

    • Higher Download Rates: Special Issue articles are downloaded twice as frequently compared to those in regular issues, reflecting the relevance and interest of the focused topic. This increased engagement amplifies the reach of your work.
    • More Citations: On average, Special Issue articles receive 20% more citations within the same period than articles published in standard issues. By contributing to a Special Issue, you enhance your research's visibility and citation potential, which is crucial for building your academic reputation.

  3. Rigorous and Quick Peer Review Process:

    • Submissions to the Special Issue undergo a rigorous peer review process by at least two independent experts. This ensures that only high-quality, original, and novel research is published.
    • Faster Turnaround: The entire process, from submission to publication, is designed to be quick and efficient. Special Issues often operate on an accelerated timeline, immediately after acceptance ensuring that your research reaches the academic community without unnecessary delays. You can expect timely feedback and a smooth publication process.

We encourage researchers and clinicians to prepare their submissions for this upcoming issue and contribute to advancing the field of cell death research and its therapeutic applications. Stay tuned for further details on submission deadlines and publication dates.